Key facts
- This page summarizes John W. Higuchi's Form 4 filing for Lipocine Inc. (LPCN).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 04 Jun 2026, 16:05.
John W. Higuchi - 03 Jun 2026 Form 4 Insider Report for Lipocine Inc. (LPCN)
- Reporting relationship
- Director
- Issuer ticker
- LPCN
- Reported as of
- 03 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Jun 2026, 16:05:24 UTC
- Prior SEC filing
- 07 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ John W. Higuchi
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
John W. Higuchi filed Form 4 for Lipocine Inc. (LPCN) on 04 Jun 2026.
Change
- Previous filing in this sequence was filed on 07 Apr 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001579891
Primary reporting owner
Higuchi John W.
- Relationship
- Director
- Address
- C/O 675 ARAPEEN DR, SUITE 202, SALT LAKE CITY
- Signature
- /s/ John W. Higuchi
- Signature date
- 04 Jun 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LPCN
transaction
Derivative
Common Stock (Right to Buy)
Award
- Transaction value
- Shares
- +1,764
- Change %
- +15%
- Price
- $2.19*
- Shares after
- 13,290
- Date
- 03 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,764
- Exercise price
- $2.19
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
100% vesting upon one year from date of grant.